Our Approach

Laboratory Approach

  • SHEPHERD pursues drug development in a platform agnostic manner letting biology drive how we target specific rare cancers

    We take a big data and AI approach to aid in the identification of new therapies and collaborate with key opinion leaders in both academia and industry to ensure access to the latest information and tools

  • SHEPHERD is committed to developing long term relationships with patients and patient foundations to help guide our approach and achieve optimal outcomes